Zinc Acetate Anhydrous

CHEMBL1200928 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
183.5 g/mol
LogP
Phase
4

Zinc acetate anhydrous is the non-hydrated form of zinc acetate, used for the same therapeutic indications including Wilson's disease management (blocking intestinal copper absorption through metallothionein induction) and zinc deficiency supplementation. The anhydrous form may have different solubility and bioavailability characteristics compared to the hydrated form but provides equivalent zinc supplementation and copper-blocking activity. It is also studied for cardiometabolic effects of zinc in conditions such as heart failure.

分子量

183.5000 g/mol

TPSA

80.30 Ų

治療領域

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(=O)[O-].CC(=O)[O-].[Zn+2]

InChI

InChI=1S/2C2H4O2.Zn/c2*1-2(3)4;/h2*1H3,(H,3,4);/q;;+2/p-2

Molecular Formula

C4H6O4Zn

HBD / HBA

- / 4

回転可能結合数

0

重原子数

9

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

Zinc acetate anhydrous is the non-hydrated form of zinc acetate, used for the same therapeutic indications including Wilson's disease management (blocking intestinal copper absorption through metallothionein induction) and zinc deficiency supplementation. The anhydrous form may have different solubility and bioavailability characteristics compared to the hydrated form but provides equivalent zinc supplementation and copper-blocking activity. It is also studied for cardiometabolic effects of zinc in conditions such as heart failure.

Yes, Zinc Acetate Anhydrous is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200928. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 11192. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.